CLINICAL_TRIALS
trial_result
· 2020-04-17
Clinical Trial Update: RCT on the Efficacy of Methotrexate for the Prevention of GTD [Phase 3]
Summary
Phase 3 randomized trial evaluating methotrexate for prevention of gestational trophoblastic disease in hydatidiform mole has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of the Philippines | Conditions: Hydatidiform Mole | Phase 3 | Status: COMPLETED